CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PharmaTimes
Original article

Atsena gains EMA orphan status for two gene therapies

RegulatoryapprovedPositive
AI Analysis

Summary

Atsena has received EMA orphan drug designation for two gene therapies, which supports advancement toward pivotal trials for these emerging candidates.

Outcome Details

EMA orphan drug designation granted for two gene therapies

Importance:6/10
Sentiment:
0.70
orphan druggene therapyEMAregulatory

Read the original article

Published by PharmaTimes on July 29, 2026 10:53 AM

Read Original